[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
Public comments (Japanese Pharmacopoeia) (Fiscal year 2020)
Closed public comments
-
March, 2021
JP Drafts (March 2021)
Comment period:From March 1, 2021 To May 31, 2021
-
September, 2020
JP Drafts (September 2020)
Comment period:From September 7, 2020 To November 30, 2020
-
June, 2020
JP Drafts (June 2020)
Comment period:From June 5, 2020 To August 31, 2020
-
March, 2020
JP Drafts (March 2020) No.2
Comment period:From March 6, 2020 To May 31, 2020